AKBLF (Alk-Abello AS) EV-to-EBITDA : 35.25 (As of Sep. 22, 2024)

View and export this data going back to 2009. Start your Free Trial

What is Alk-Abello AS EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Alk-Abello AS's enterprise value is $6,035.8 Mil. Alk-Abello AS's EBITDA for the trailing twelve months (TTM) ended in Jun. 2024 was $171.2 Mil. Therefore, Alk-Abello AS's EV-to-EBITDA for today is 35.25.

The historical rank and industry rank for Alk-Abello AS's EV-to-EBITDA or its related term are showing as below:

AKBLF' s EV-to-EBITDA Range Over the Past 10 Years
Min: 9.88 Med: 38.42 Max: 93.66
Current: 34.16

During the past 13 years, the highest EV-to-EBITDA of Alk-Abello AS was 93.66. The lowest was 9.88. And the median was 38.42.

AKBLF's EV-to-EBITDA is ranked worse than
84.53% of 459 companies
in the Biotechnology industry
Industry Median: 8.73 vs AKBLF: 34.16

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-09-22), Alk-Abello AS's stock price is $27.0328. Alk-Abello AS's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was $0.450. Therefore, Alk-Abello AS's PE Ratio for today is 60.07.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.

Alk-Abello AS EV-to-EBITDA Historical Data

The historical data trend for Alk-Abello AS's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alk-Abello AS EV-to-EBITDA Chart

Alk-Abello AS Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-EBITDA

Get a 7-Day Free Trial

70.33

73.59

70.26

30.61

24.84

Alk-Abello AS Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
EV-to-EBITDA	Get a 7-Day Free Trial															21.98	21.15	24.84	27.50	28.77

Competitive Comparison of Alk-Abello AS's EV-to-EBITDA

For the Biotechnology subindustry, Alk-Abello AS's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Alk-Abello AS's EV-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Alk-Abello AS's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Alk-Abello AS's EV-to-EBITDA falls into.

Alk-Abello AS EV-to-EBITDA Calculation

Alk-Abello AS's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA	=	Enterprise Value (Today)	/	EBITDA (TTM)
	=	6035.755	/	171.234
	=	35.25

Alk-Abello AS's current Enterprise Value is $6,035.8 Mil.
Alk-Abello AS's EBITDA for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $171.2 Mil.

Alk-Abello AS (OTCPK:AKBLF) EV-to-EBITDA Explanation

Alk-Abello AS's PE Ratio for today is calculated as:

PE Ratio	=	Share Price (Today)	/	Earnings per Share (Diluted) (TTM)
	=	27.0328	/	0.450
	=	60.07

Alk-Abello AS's share price for today is $27.0328.
Alk-Abello AS's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.450.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

Alk-Abello AS EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Alk-Abello AS's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Alk-Abello AS Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alk-Abello AS (OTCPK:AKBLF) » Definitions » EV-to-EBITDA

Comparable Companies

Traded in Other Exchanges

0OIR:UK ALK B:Denmark 4AJ0:Germany

Address

Boge Alle 6-8, Horsholm, DNK, DK-2970

Website

https://www.alk.net

Alk-Abello A/S is a biotechnology company that focuses on pharmaceutical prevention, diagnosis, and treatment of allergies. The company is focused on respiratory diseases, including allergic rhinitis and allergic asthma. Moreover, the firm specializes in venom immunotherapy for patients suffering from bee and wasp allergies. The company's treatments induce a protective immune response that provides sustained symptom relief. Its primary focus is on allergy patients whose disease is not well controlled, despite the use of symptom-relieving medication.